tanshinone has been researched along with rifampin in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | tanshinone (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, X; Liu, L; Wang, L; Yang, Y; Zhang, X | 1 |
1 other study(ies) available for tanshinone and rifampin
| Article | Year |
|---|---|
Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2.
Topics: Abietanes; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Chemical and Drug Induced Liver Injury, Chronic; Epigenesis, Genetic; Female; HEK293 Cells; Hepatocytes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Organic Anion Transporters, Sodium-Dependent; Rifampin; Symporters | 2020 |